YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
(RTTNews) - The following biotech stocks reached 52-week highs on August 7, 2026, driven by key catalysts such as positive quarterly reports or upcoming conference participation. Delcath Systems Inc. (DCTH) Delcath Systems is an interventi…
(Bloomberg) -- The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts. Most Read from Bloomberg Yemen's…
(RTTNews) - The following biotech stocks reached a 52-week high on July 20, 2026, driven by key catalysts such as upcoming clinical trial launches and the prospective release of data from these studies. Xencor Inc. (XNCR) Xencor is a clini…
(RTTNews) - Hemab Therapeutics (COAG) presented new clinical and preclinical data for its lead candidate Sutacimig at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris, underscoring its potential to tran…
(RTTNews) - The following biotech stocks touched a 52-week high on July 14, 2026, attributable to key catalysts like encouraging clinical trial results and the launch of new programs supporting research advancements. Hemab Therapeutics Hol…
HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of peak thrombin generation and activated par…
[Business Stock Exchange Trading Concepts] Rawpixel Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY…
aprott/iStock via Getty Images Shares of Hemab Therapeutics (COAG [https://seekingalpha.com/symbol/COAG]) and Seaport Therapeutics (SPTX [https://seekingalpha.com/symbol/SPTX]) surged on Friday as the clinical-stage biotechs made their tra…
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, April 30, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics Holdings, Inc. (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation di…
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Blood disease specialist Hemab Therapeutics and brain drug developer Seaport Therapeutics bot…